New Federal Health Reform Law Includes “Sunshine” Reporting Requirements for Drug and Device Manufacturers

more+
less-

On March 23, President Obama signed into law the Patient Protection and Affordable Care Act (Pub. L. No. 111-148). Section 6002 of the Act (the “new federal law”) creates significant new obligations for drug and device manufacturers, by requiring annual disclosure filings detailing their financial relationships with physicians and teaching hospitals. These new federal requirements are also known as the “Sunshine” provisions, since they were originally proposed in 2007 as the “Physician Payments Sunshine Act” by Senators Charles Grassley and Herb Kohl.

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.